Company / CapEx per Share
AGIOS PHARMACEUTICALS, INC. CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.08
FY2025
5-year range
$0.02 / $0.26
FY2021-FY2025
Trend
+150.7%
vs FY2024
Sector context
#65 of 192
Health Care
What the data says
At $0.08, AGIOS PHARMACEUTICALS, INC.'s capex per share ranks #65 of 192 in the Health Care sector. CapEx per Share has fluctuated over the past 10 years, ranging from $0.02 in FY2023 to $0.26 in FY2016.
Based on SEC 10-K filings.
0.08 in FY2025 with a 5-year CAGR of -5.9%.
Improved from $0.02 to $0.08 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -33.7%
- 5-Year CAGR
- -5.9%
- 10-Year CAGR
- -
Sector benchmark
#65 of 192 in Health CareTop 34% of 192This company $0.08 Sector average $2.46
▼
-96.9% below sector average
Key checks
Key Insights
- In FY2025, capex per share increased 150.7% year-over-year.
- Ranks #65 out of 192 companies in the Health Care sector.
- Peak capex per share was recorded in FY2016.
- Lowest capex per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.08 | +150.7% |
| FY2024 | $0.03 | +65.9% |
| FY2023 | $0.02 | -93.0% |
| FY2022 | $0.26 | +173.4% |
| FY2021 | $0.09 | -7.0% |
| FY2020 | $0.10 | -50.6% |
| FY2019 | $0.21 | +1.7% |
| FY2018 | $0.20 | +85.3% |
| FY2017 | $0.11 | -58.3% |
| FY2016 | $0.26 | +654.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026